OBJECTIVE: To review published reports of first-trimester medical abortion regimens that do
not include mifepristone. METHODS: Reports listed in Pubmed and Medline on prospective …

BACKGROUND: Nonsurgical abortion methods have the potential to improve access to high-
quality abortion care. Until recently, availability and utilization of mifepristone medical …

Objective To compare the efficacy of 100 mg and 200 mg of mifepristone and 24‐and 48‐
hour intervals to administration of 800μg vaginal misoprostol for termination of early …

Objective To assess women's acceptability, the efficacy and side effects of sublingual versus
vaginal administration of misoprostol in combination with mifepristone for medical abortion …

A group of 120 women with gestations from 64 to 84 days received 800 μg of vaginal
misoprostol every 24 h for a maximum of three doses without performing postexpulsion …

OBJECTIVE: To estimate the clinical benefit of pretreatment with mifepristone followed by
misoprostol compared with misoprostol alone for second-trimester abortion. METHODS: Two …

INTRODUCTION: A growing body of literature has shown that misoprostol alone could be
effective for early medical abortion. We evaluated seven potential regimens in women up to …

Objective To investigate the clinical efficacy of the combination of mifepristone and an orally
active prostaglandin, misoprostol, for early medical termination. Design Women with …

BACKGROUND: A combination of mifepristone and misoprostol provides an effective
method of medical abortion for early pregnancy. A new route of administration of …

Objective To examine the clinical efficacy of mifepristone 600 mg followed on the same day
or two days later by misoprostol 400μg orally in women undergoing medical termination of …